# Summit Therapeutics Inc.: Form 8-K, filed Jun 17, 2025

- Company: [Summit Therapeutics Inc.](/companies/smmt.md) (CIK 1599298)
- Form: 8-K
- Filed: 2025-06-17
- Accepted by EDGAR: Jun 17, 2025, 16:13 ET
- Period: 2025-06-12
- Accession: 0001599298-25-000116
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1599298/000159929825000116/smmt-20250612.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1599298/000159929825000116/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1599298/000159929825000116/smmt-20250612.htm

Filed Jun 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001599298-25-000116. Last ingested by Listed: Nov 4, 2026, 19:36 ET. No prices; not investment advice.
